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ABSTRACT 
     In genomics, the ability to amplify rare transcripts has enabled rapid advances in the understanding of 
gene expression patterns in human disease. The inability to increase the copy number and to detect the signal 
of rare proteins as unique species in biological samples has hindered the ability of proteomics to dissect 
human disease with the same complexity as genomic analyses. Advances in nanotechnology have begun to 
allow researchers to identify low-abundance proteins in samples through techniques that rely upon both 
nanoparticles and nanoscale devices. This review describes some of the physical and chemical principles 
underlying nanomaterials and devices and outlines how they can be used in proteomics; developments which 
are establishing nanoproteomics as a new field. Nanoproteomics will provide the platform for the discovery 
of next generation biomarkers. The most promising candidates for nanoproteomics, namely carbon 
nanotubes and nanowires, quantum dots and nanoscopic gold particles, offer several advantages such as high 
sensitivity, real-time measurements and improved reproducibility. 
 




     Proteomics has witnessed rapid growth over 
the last decade, with increasing emphasis on 
development of robust and high-throughput 
technologies to understand the diverse proteome. 
Researchers have gone beyond traditional 
techniques and approached promising disciplines 
like nanotechnology to satisfy the growing 
demands of studying numerous complex and 
functional proteins. Applications of 
nanotechniques in proteomics have steadily been 
growing over the years and it has established itself 
as a technical platform for sensitive detection of 
low abundance proteins in shorter time. The main 
focus of this inter-disciplinary approach is to 
increase the sensitivity and improve 
biocompatibility. The most promising candidates 
for nanoproteomics, namely carbon nanotubes and 
nanowires, quantum dots and nanoscopic gold 
particles, offer several advantages such as high 
sensitivity, real-time measurements and improved 
reproducibility.Proteomics, the study of proteins 
expressed by a genome, is now an established 
field. Since the term was first coined at a 
scientific conference in Italy by Wilkins in 1994, 
proteomics has gone through successive 
revolutions of method optimization and 
technology development. The key has always 
been in the development of high throughput 
methods. With the introduction of immobilized 
pH gradients 2-DE has become the workhorse of 
protein separation and a quick method for 
obtaining protein expression patterns. Up to 10 
000 distinct protein and peptide spots can be 
separated on one gel [1, 2]. 
 
1.2. Nanomaterials 
     Inorganic nanomaterials, whose features are 
controlled at the nanometer scale (1 to 100 nm) 
possess many unique and advantageous physical 
properties when applied as ultra-sensitive signal 
transducers and protein concentrators in the fields 
of molecular diagnostics and proteomics. When 
the dimensions of materials are reduced to the 
nanometer regime, their intrinsic physical 
properties can be determined by their size and 
shape as well as composition, in ways often not 
predictable from either their component atoms or 
from the properties of micrometer sized particles 
of the same composition [3]. This will be 
 




exemplified and explained in the following 
sections with specific consideration being given to 
superparamagnetic nanoparticles and their 
primary use in the magnetic separation of bio-
molecules [4], quantum dot (QD) (semiconductor) 
and plasmonic (metallic)nanoparticles as 
improved labels and optical reporters [5-7] and 




     Nanomaterials have long played a part in 
proteomics, however the difference between these 
earlier nanomaterials and the new nanomaterials 
is the level of understanding of the relationship 
between their structure and the properties of their 
materials leading to the ability to engineer the 
latter to suit the applications much better.In the 
near term nanotechnology will have a major 
impact on proteomics and diagnostics (as well as 
imaging and therapy). In molecular diagnostics 
the impact will lead to new devices and sensing 
modes whilst in proteomics it will extend and 
augment existing methods. 
As a result, it is still impossible to detect all 
protein molecules existing in a biological 
material. This is the main problem of proteomics. 
The second problem of proteomics is the high 
dynamic range of concentrations of protein 
molecules existing in biomaterial, the so-called 
dynamic concentration barrier.So proteomics 
needs new technologies that make it possible to 
register single molecules in the presence of high 
abundant molecules. Nanotechnology can play a 
role in these new technologies. Even now, these 
technologies have the ability to register and 
visualize single macromolecules and their 
complexes, as well as single nanoparticles. 
Among the nano-technologies are methods of 
scanning electron microscopy, near field scanning 
microscopy and other microcanteliver techniques, 
and nanowire and nanopore detectors. [9,10] 
The second approach that will enable the 
detection limit as well as the dynamic 
concentration barrier to be overcome are 
technologies that, like the polymerase chain 
reaction, can multiply single protein molecules. 
Such technologies are currently being developed, 
and without any doubt, their success will depend 
on the predominance of nanotechnologies in this 
sphere because manipulating single molecules is 
the subject matter of nanotechnology.The 
development of methods such as 
nanoelectrophoresis and nanochromatography 
gives hope that these technologies will deal with 
single molecules and not with concentration 
parameters; in other words, nanopreparative 
technology concerns the separation of single 
molecules, their detection and visualization. At 
the same time, of course, it is important to 
recognize that the current technologies of 
proteomics, such as multidimensional 
electrophoresis, multidimensional 
chromatography in combination with mass 
spectrometry in its modern types, as well as 
methods of quantitative estimation of proteins in 
biomaterials,are so highly developed that they 
should be retained unchanged and new methods 
using new technology should simply be 
introduced. At the same time,existing 
nanotechnologies on the way to converting 
protein microarrays into nanoarrays can undergo 
significant development. 
With the solution of this problem, proteomics will 
attain a new technology that seems to be more 
efficient than technologies already in 
existence.Summarizing the reasons for 
introducing a nanotechnology section into 
PROTEOMICS, there are two of the main 
problems of proteomics:the first is fundamental 
and lies in the detection of the number of proteins 
molecules in a biomaterial, in analogy with 
genomics, and the second is applied and lies in the 
detection of protein biomarkers for different 
diseases. 
The first problem will be solved after the creation 
of high-throughput detectors for counting single 
molecules instead concentration detectors.The 
second problem seems to be polysemantic, 
namely biomarkers for diseases of the 
cardiovascular system, in particular cardiac 
infarction, do not need nanotechnologies [9] 
 
2. Nanoproteomics and biomarker discovery 
     Biomarker discovery requires sensitivity and a 
comprehensive coverage of bio-molecules which 
may represent the alteration caused by the disease 
of interest. Protein candidate biomarker discovery 
often involves identifying proteins found at 
extremely low concentrations. As highlighted in 
 




the previous sections there are three main areas 
where tradi-tional proteomics is unable to offer 
adequate solutions for biomarker discovery and 
diagnostics. Firstly in the separation of complex 
protein mixtures, second, the detection and 
identification of low abundant components and 
third, the ability to analyze samples with a 
dynamic range above 3.5 orders of magnitude. 
there are only two main areas where 
nanoproteomics has been used in biomarker 
discovery: nanostructured surfaces for the 
enhancement of proteomic analysis via MS and 
RP protein microarrays; and nanoporous materials 
for selective binding and fractionation of proteins 
and protein fragments. 
 
2.1. Nanostructured surfaces 
     MALDI-MS has been the most widely used 
method for protein identification using suitable 
organic matrixes. Although these matrices have 
been widely used there are several issues which 
need improvement. The most obvious problem is 
the interference of matrix peaks in the low 
molecular weight region which means that peptide 
data cannot be collected below 800 m/z. The other 
problem is finding the suitable matrix for the 
sample. To solve these problems, the use of 
several kinds of metal and metal oxide particle 
has been reported in the literature, such as Al, Mn, 
Mo, Si, Sn, TiO2,W, WO3, Zn, and ZnO [10], 
sol-gel-deposited TiO2 [11],ordered mesoporous 
WO3-TiO2 [12], Au-NPs [13], and 
selfassembling Ge nanodots [14]. Apart from 
metal and metal oxide nanoparticles, carbon 
nanotubes have also been used [15]. 
Nanotechnology techniques used in 
semiconductor processing has been applied to 
create MALDI-MS targets for matrix free 
ionization such as column/void-network silicon 
thin films prepared by plasma-enhanced chemical 
vapor deposition [16], single-crystal silicon NWs 
deposited on silicon wafer [17], ordered arrayed 
silicon nanocavity that was lithographically 
fabricated on a silicon wafer [18] and ordered 
arrays of submicrometer groove structures [19]. 
Another example of using nanostructured 
surfaces, is a study by Gaspari et al. [20] in which 
silica-based nanoporous surfaces were used to 
capture low molecular weight peptides from 
human plasma. The surface was fabricated by 
coating silicon chips with a 500 nm thick 
nanoporous film of silicon oxide. The average 
pore size was estimated to be about 7 
nm.Harvested peptides were analyzed by 
MALDI-TOF MS and 70 peaks were found in the 
800–10 000 m/z range. This method was able to 
detect peptides in the ng/mL concentration level. 
Tailoring of the surface allows selective 
enrichment of specific protein or peptide classes. 
This study used the matrix-free 
desorption/ionization on silicon method first 
reported by Wei et al. [21].RP protein 
microarrays are also using nanostructured surface 
for proteomics. These arrays enable the 
highthroughput screening of PTMs of signalling 
proteins with diseased cells. In a recent report by 
Geho et al. [22] used QDs as reporter agents for 
the amplification of microarray sensitivity taking 
advantage of their multiplexing potential. 
Instead of nitrocellulose, which has high intrinsic 
autofluorescence,silicon was used as a potential 
microarray surface. Through semiconductor 
etching techniques, large surface areas can be 
created on silicon to enhance protein binding. 
 
2.2. Nanoporous materials 
     In search for a reproducible and highly specific 
method for the isolation of representative protein 
signatures of a particular disease state, researchers 
looked for technological advancement in 
fractionation and reproducible binding of 
characteristic molecules from body fluids. One of 
the new solutions which emerged as a result of 
this is the use of nanoporous material surfaces as 
a fractionation tool for serum-based analysis and 
biomarker discovery [23,24,25,26]. Geho et al. 
for example used nanoporous silicon wafer to 
selectively deplete a fraction of proteins from 
serum. By controlling the pore size of nanoporous 
glass beads, distinct subsets of the proteome were 
harvested. The protein and peptide profiles of 
fractionated and unfractionated serum samples 
were compared by SELDI-MS. 
Nanoporous materials are also used in 
chromatography using monolith supports. For an 
overview of monoliths in proteomics technology 
see a review from Josic [27]. The combination of 
high flow rates, high surface area and well 
established surface modification procedures 
makes monolithic columns and capillary packings 
 




suitable for many aspects of proteomics from 
sample preparation to enzymatic digestion to 
peptide separations. One of the strengths of 
monoliths is the ability to tailor the pore sizes and 
distributions to match the particular application. 
Rainer et al. [27,28] used monolithic capillary 
columns for fractionation of broad range serum 
proteins and peptides which were separated using 
an immobilized metal ion affinity 
chromatography column. The eluted peptides 
were identified by MALDI-TOF MS. 
 
3. Nanotechnology and molecular diagnostics 
     As medical diagnostics is more and more 
relying on molecular markers and highly specific 
therapies targeted at disease specific receptors, 
novel methods are emerging for the detection and 
quantification of low abundant bio-molecules. 
Diagnosis requires selectivity and quantification. 
“Selectivity”refers to how well an assay can 
detect particular molecules in a complex mixture 
without interference from other molecules. 
Biomarker validation and measurement on the 
other hand depends on accurate and reproducible 
protein quantitation.The emergence of novel 
nanotechnologies not only increased sensitivity as 
it was highlighted in the previous section but also 
enabled biologists to achieve high specificity by 
enriching very low abundant proteins from 
complex mixtures.This section gives examples of 
nanomaterials applied in the field of biomarker 
measurement and clinical diagnostics enabling 
cheaper and more accurate solutions for Point-of-
Care (PoC) home-tests.Building on the acquired 
knowledge, nanomaterials are now ready to be 
employed in the field of molecular diagnostics 
(Table1), taking it from hospital laboratories to 
the patient [29]. 
 
3.1. Au-NPs 
     Au-NPs are considered as the industry-
standard in nanotechnology.First introduced to the 
PoC diagnostics market in the form of a 
pregnancy test and now adopted by a range of 
PoC lateral-flow immunochromogenic tests, such 
as Phadia’s ImmunoCAP Rapid test for specific 
IgE against ten common allergens, and Merck’s 
Singlepath and Duopath tests for food borne 
pathogens, Au-NPs still serve as one of the few 
examples of a successful integration between the 
area of nanotechnology and PoC diagnostics. Au-
NPs are chosen above dyed latex beads as their 
higher diffusion rate results in improved mixing 
of the analyte and capture particle,and an increase 
in sensitivity. Their small size and large molar 
absorption coefficient also leads to the formation 
of a dense line of highly visible particles forming 
at the capture line, providing clearer read-out. 
[29] 
 









     Gold (as well as silver) nanoparticles have also 
played a major part in SERS, another optical 
technique with widespread applications in 
molecular diagnostics. Two SERS formats are 
commonly used as signal transducers in 
diagnostics; labelfree SERS assays where the 
SERS spectrum of the analyte itself is measured 
[30], and the use of SERS reporter tags in 
sandwich immunoassay formats [31,32]. 
An example of the latter, are Nanoplex-Biotags, 
which consist of Au-NPs coated with unique 
SERS-active reporter molecules that are then 
protected and made biocompatible with a silica 
shell.As well as label-free formats based on 
antibody coated SERS active substrates [30] the 
in vivo quantitative measurement of glucose has 
also been achieved. 
 
3.3. QDs 
      Rather than offering a new paradigm in 
molecular diagnostics, QDs offer important 
improvements in established fluorescent-based 
diagnostics and sensing. Due to the advantageous 
spectral properties of QDs versus organic 
fluorophores,QDs improve the multiplexing 
capabilities, detection limits and robustness of 
fluorescence methods .With the development of 
thin-film GMR and Spin Dependent Tunnelling 
materials–materials whose resistance is modulated 
by external magnetic fields–extremely 
sensitive,miniaturized magnetic sensors have been 
fabricated [33,34]. 
 For molecular diagnostic applications, these have 
often been in the format of magnetic 
immunoassays that detect analytes bound between 
magnetic nanoparticles and a magnetic sensor. An 
applied external field is used to induce a magnetic 
moment in the superparamagnetic 
nanoparticles,creating a local magnetic field that 
is detected by the sensor. 
 
3.4. NWsensors 
     NWsensors operate on the basis that the 
change in chemical potential accompanying a 
target/analyte binding event, such as DNA 
hybridization or protein binding can act as a 
fieldeffect gate upon the NW, thereby changing 
its conductance .In an elegant proof-ofprinciple 
study it was demonstrated that boron-doped 
silicon nanowires (SiNW) could be used as highly 
sensitive, realtime,electrically based sensors for 
biological and chemical species [35]. To this end, 
Zheng et al. [8] described a multiplexed electrical 
detection of cancer markers using SiNW field-
effect devices in which distinct NWs and surface 
receptors are incorporated into arrays (see Fig.1).  
 
 
Figure1. NW-based detection of single molecules. (A) 
Schematic showing of a NWdevice with antibodies on the 
surface capturing a single cell; (B) same as A capturing 
proteins and (C), NW device capturing DNA molecules. 
Adapted from [8]  
 
 
Figure 2. Functionalized manocantiliver array. (A) 
Schematic illustration of a silicon nanocantiliver array with 
receptor molecules on the surface and target proteins above; 
(B) same as before after protein binding showing the 
cantilever band owing to the applied force of the binding 
event. Adapted from [38]. 
 
 





     Nanocantilevers are the most simplified 
nanoelectromechanical systems based device and 
are an example of how low-cost silicon micro-
fabrication technology can produce nanostructures 
whose size-dependant mechanical properties form 
the basis of a label-free biosensing platform with 
multiplexing capability. As described earlier, 
analyte binding to nanocantilevers results in a 
measurable deflection due to changes in surface 
stress (as illustrated schematically in Fig.2). Such 
devices have recently been used for the detection 
of cardiac biomarkers [36]. 
 
CONCLUSIONS AND OUTLOOK 
      Proteomics provides methods for correlating 
the vast amount of genomics information that is 
becoming available with the equally vast protein 
information that is being produced through 
analysis of cells under normal versus altered 
states.The development of nanotechnology, for 
example in the area of nanoparticles demonstrates 
that research is rising to this challenge, as these 
technologies will revolutionize the direction of 
proteomics research in future.Looking at where 
nanotechnology is currently and where it may be 
in the future in relation to proteomics and 
diagnostics we can distinguish two trends; 
evolution and revolution.The evolutionary trend 
uses nanotechnology to improve current 
approaches by providing materials and devices 
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